Duke at AHA: Monday, November 15, 2010

Duke Heart Center brings you highlights of today's news and commentary from the AHA’s annual Scientific Sessions occurring in Chicago.

Late Breaking Research Session:

In the largest study of its kind, Duke led research shows ability of new agent to prevent strokes in patients with atrial fibrillation.

Read more about the ROCKET AF trial (PDF)

Video: Watch interview with study investigators Dr. Robert Califf, Dr. Manesh Patel, Dr. Ken Mahaffey and Dr. Keith Fox

ROCKET-AF: Stroke Prevention Using the Oral Direct Factor Xa Inhibitor Rivaroxaban Compared with Warfarin in Patients with Nonva from DukeTranslational Medicine Inst on Vimeo.

Late Breaking Research Session:

New left ventricular assist device technology is evaluated as a bridge to transplant in advanced heart failure.

Read more about the ADVANCE trial (PDF)

Video: Watch study investigator Dr. Keith Aaronson discuss ADVANCE with Dr. Duane Pinto

Dr. Keith Aaronson and Dr. Duane Pinto discuss: Evaluation of the Heartware HVAD Left Ventricular Assist Device System for the T from DukeTranslational Medicine Inst on Vimeo.

Late Breaking Research Session:

The first randomized trial provides more information about PFO closure for prevention of stroke and TIA.

Read more about the CLOSURE I trial (PDF)

Video: Watch study investigator Dr. Anthony Furlan discuss CLOSURE I with Dr. Duane Pinto

Dr. Anthony Furlan and Dr. Duane Pinto discuss: CLOSURE I Trial from DukeTranslational Medicine Inst on Vimeo.

More Videos from Duke TV:

Dr. Kenneth Ellenbogen presents: SMART AV: Comparison of AV Optimization Methods Used in Cardiac Resynchronization Therapy (CRT)

Dr. Kenneth Ellenbogen presents: SMART AV: Comparison of AV Optimization Methods Used in Cardiac Resynchronization Therapy (CRT) from DukeTranslational Medicine Inst on Vimeo.

Dr. Deepak Voora presents: A Whole Blood RNA Signature Accurately Classifies Multiple Measures of Platelet Function on Aspirin in Healthy Volunteers and Highlights a Common Underlying Pathway

Dr. Deepak Voora presents: A Whole Blood RNA Signature Accurately Classifies Multiple Measures of Platelet Function on Aspirin i from DukeTranslational Medicine Inst on Vimeo.

Duke in the News at AHA:

The New York Times -- Good News & Bad from a Heart Study

The Wall Street Journal -- New Heart Medications Gain Clout

USA Today -- New Pill Prevents Strokes with Less Bleeding Risk for Atrial Fib Patients

Associated Press -- Study: New Blood Thinner Works as well as Coumadin

ABC News -- Pill Prevents Stroke in High Risk Patients

Bloomberg -- Bayer, J&J's Xarelto Bests Warfarin Without Raising Bleeding Risk

News & Observer -- Ineffective drug shows flawed test process

The Associated Press -- Studies: Drug, device help treat heart failure (PDF)

The Wall Street Journal -- Drug Study Gives J&J Cold Comfort (PDF)

Los Angeles Times -- Major new study shows Natrecor is safe, but not very effective (PDF)

Bloomberg Businessweek -- Medtronic, HeartWare Data Shows Heart-Failure Success (PDF)

Want more news and views from AHA? Visit http://www.dukehealth.org/heart_center/health_library/news/duke-heart-center-at-american-heart-associations-scientific-sessions each day to see the latest videos and gain context, discussion, opinion about what the new data mean for patients and practice. Get live updates direct from AHA on the Duke Cardiology Fellows' Blog.
 

end fo content area